標(biāo)題: Titlebook: Cancer Prevention II; Hans-J?rg Senn,Ursula Kapp,Florian Otto Conference proceedings 2009 Springer-Verlag Berlin Heidelberg 2009 ER-negati [打印本頁] 作者: Malnutrition 時間: 2025-3-21 19:31
書目名稱Cancer Prevention II影響因子(影響力)
書目名稱Cancer Prevention II影響因子(影響力)學(xué)科排名
書目名稱Cancer Prevention II網(wǎng)絡(luò)公開度
書目名稱Cancer Prevention II網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cancer Prevention II被引頻次
書目名稱Cancer Prevention II被引頻次學(xué)科排名
書目名稱Cancer Prevention II年度引用
書目名稱Cancer Prevention II年度引用學(xué)科排名
書目名稱Cancer Prevention II讀者反饋
書目名稱Cancer Prevention II讀者反饋學(xué)科排名
作者: Chagrin 時間: 2025-3-21 23:46 作者: 猛擊 時間: 2025-3-22 01:22
Cancer Prevenpinon in the Developing World: Mission Impossible?lso thought to be a hallmark of the developed world, while on the contrary cancer is set to become the newest epidemic in the developing world..Based on the most recently estimated incidence rates, the 11 million cancer cases diagnosed in 2002 will reach roughly 17 million in 2020 and 27 million by 作者: 新娘 時間: 2025-3-22 06:14
Is Cancer Prevention Ever Going to Be Profitable?gets. Hence, the question arises of how many resources should be devoted to the management of cancers, given that resources are scarce and many other fields and specialities are competing for these resources. This paper addresses the question of whether preventive measures in oncology eventually pay作者: 滲透 時間: 2025-3-22 09:34
The EPIC Study: An Update obtaining ethical approval from the International Agency for Research on Cancer (IARC) Ethical Review Committee and from the local ethical committees at the participating centres, participants were invited to take part in the study. After signing an informed consent agreement EPIC participants were作者: 嚴(yán)厲譴責(zé) 時間: 2025-3-22 16:17
Cancer Prevention by Vaccination Against Hepatitis Bccination program in Taiwan, chronic HBV infection (HBsAg seropositive) rates in the general population below 20 years of age have revealed a remarkable reduction from 10%–17% before the vaccination program to 0.7%–1.7% after the program. HCC incidence rate in children 6–14 years old also fell from 作者: 嚴(yán)厲譴責(zé) 時間: 2025-3-22 20:27
The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancerrst degree female relatives (mother, sister, daughter) with a history of breast cancer and 9.2% of the women had a personal history of LCIS. A history of atypical hyperplasia of the breast was noted in 22.7% of the participants. The mean predicted 5-year risk of developing breast cancer among the st作者: SLUMP 時間: 2025-3-22 23:18 作者: 討好女人 時間: 2025-3-23 05:03 作者: BIBLE 時間: 2025-3-23 08:34 作者: 眨眼 時間: 2025-3-23 10:20
Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer PreventionPSA level of no more than 4 ng/ml and a digital rectal exam (DRE) not suspicious for prostate cancer. Participants were randomized to receive selenium (200 μg/ day of . -selenomethionine) and/or vitamin E (400 IU/day of .-alpha-tocopheryl acetate) supplementation for a minimum of 7 years (maximum of作者: Countermand 時間: 2025-3-23 16:01
Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoidsy assessed the activity of novel compounds derived from the oleanolic acid triterpenoid, called CDDO-Me and CDDO-Imm. These compounds show a potent anti-angiogenic activity at low dosages. In vivo they inhibit angiogenesis in the Matrigel sponge assay and in KS-Imm (an immortalized Kaposi‘s sarcoma 作者: bronchodilator 時間: 2025-3-23 21:16 作者: 和平主義者 時間: 2025-3-23 22:27
0080-0015 97%–98% or even a greater percentage of health budgets is spent for curative and palliative/rehabilitative m- icine. Since a meager 2%–3% of national health budgets is for preventive medicine, 978-3-642-08881-0978-3-540-69297-3Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 感情脆弱 時間: 2025-3-24 05:02
Key Technologies on New Energy Vehicleslinical tri-als—also have become more focused based on results from basic science leads. The expansion of preclinical chemoprevention studies and greater attention to “first-in-human” prevention trials that safely shorten the timeline for new drug development are needed. The development of a prevent作者: 狼群 時間: 2025-3-24 07:56
https://doi.org/10.1057/9781137025630 cancer prevention in the literature have been directed towards the most common malignant diseases (as assessed by incidence) such as cancer of the breast, colon, lung and prostate. We argue that incidence is a poor marker for selecting secondary prevention programs. Incidence may be a misleading in作者: Pillory 時間: 2025-3-24 11:00 作者: 雇傭兵 時間: 2025-3-24 17:44
Chris R. de Freitas,Martin Perrygets. Hence, the question arises of how many resources should be devoted to the management of cancers, given that resources are scarce and many other fields and specialities are competing for these resources. This paper addresses the question of whether preventive measures in oncology eventually pay作者: 擦試不掉 時間: 2025-3-24 19:31
New Enzymes for Organic Synthesis obtaining ethical approval from the International Agency for Research on Cancer (IARC) Ethical Review Committee and from the local ethical committees at the participating centres, participants were invited to take part in the study. After signing an informed consent agreement EPIC participants were作者: 通便 時間: 2025-3-25 00:43
https://doi.org/10.1007/978-3-319-64680-0ccination program in Taiwan, chronic HBV infection (HBsAg seropositive) rates in the general population below 20 years of age have revealed a remarkable reduction from 10%–17% before the vaccination program to 0.7%–1.7% after the program. HCC incidence rate in children 6–14 years old also fell from 作者: Gobble 時間: 2025-3-25 06:46 作者: 思想上升 時間: 2025-3-25 07:55
Calculi of Names: Free and Modalnoids (analogs of retinoids that bind and activate RXR receptors), tyrosine kinase inhibitors (such as EGFR inhibitors and dual kinase inhibitors that block EGFR and HER2/neu signaling), and cyclo-oxygenase 2 (COX-2) inhibitors all prevent ER-negative breast cancer in transgenic mice that develop ER作者: Confound 時間: 2025-3-25 11:53 作者: Terminal 時間: 2025-3-25 19:17 作者: evince 時間: 2025-3-25 21:45 作者: 謊言 時間: 2025-3-26 04:00 作者: 山羊 時間: 2025-3-26 08:14
0080-0015 Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy 作者: 下邊深陷 時間: 2025-3-26 08:38
New Era for Robust Speech Recognitione trial. This warrants further research on fenretinide mechanisms of action and potential efficacy and provides the rationale for a phase III primary prevention trial in young women at high risk for breast cancer.作者: G-spot 時間: 2025-3-26 13:43
Existence and Reference in Medieval Logicst, multicentre, randomised controlled clinical trial looking at the long-term chemopre-vention effect of esomeprazole with or without aspirin. More than 85% of the participants tolerated the medications at the initial intended doses, and the drop-out rate has been 7%; the interim analysis is due in 2011.作者: 滔滔不絕地講 時間: 2025-3-26 17:29
Free Logic and Definite Descriptionsrophage-mediated immune surveillance. This observation and data demonstrating that non-steroidal anti-inflammatory drugs (NSAIDs) protect against prostate cancer provide the justification for trials of these two agents combined with short course intermittent anti-androgen therapy in populations at high risk of prostate cancer.作者: Yag-Capsulotomy 時間: 2025-3-26 22:37 作者: 欄桿 時間: 2025-3-27 02:09
Chemoprevention of Oesophageal Cancer and the AspECT Trialst, multicentre, randomised controlled clinical trial looking at the long-term chemopre-vention effect of esomeprazole with or without aspirin. More than 85% of the participants tolerated the medications at the initial intended doses, and the drop-out rate has been 7%; the interim analysis is due in 2011.作者: frenzy 時間: 2025-3-27 07:27 作者: Exposition 時間: 2025-3-27 11:11
Conference proceedings 2009ss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy of Early Breast Cancer” as well as “Support作者: 致詞 時間: 2025-3-27 15:07
Michael I. Mandel,Jon P. Barker, a concept we termed “angioprevention.” In this manuscript we use as an example the synthetic retinoid .-(4-hydroxyphenyl)retinamide (4HPR), a molecule with confirmed clinical applications in breast cancer adjuvant therapy to prevent cancer recurrence and under evaluation in neuro blastoma and glioblastoma treatment.作者: 潛伏期 時間: 2025-3-27 19:21 作者: PLUMP 時間: 2025-3-27 23:08
Do We Make Optimal Use of the Potential of Cancer Prevention?out cancer epidemiology, causation, and preventative measures. Despite our increased understanding in these critical areas, this knowledge is not being translated adequately into initiatives that will impact public health. The recent release of the World Cancer Research Fund/American Institute for C作者: 調(diào)整校對 時間: 2025-3-28 03:38 作者: Repetitions 時間: 2025-3-28 07:59
Cancer Prevenpinon in the Developing World: Mission Impossible? in order to inform policymakers, with the aim of pushing them to act in order to tackle this looming disaster. The implementation of a cancer control plan, encompassing prevention, screening and treatment in each country, should therefore become the declared goal of all health policymakers worldwid作者: Culmination 時間: 2025-3-28 12:42 作者: Chameleon 時間: 2025-3-28 15:35
Promises and Limitations of Biomarkersd for predicting response to therapy. Ye t very few markers are brought to clinical practice, and many are not even found to be reproducible. This essay discusses chance and bias as threats to validity that can explain the huge disconnect between promise and product, along with approaches to address作者: Spinal-Fusion 時間: 2025-3-28 20:16
The EPIC Study: An Updateetween diet, lifestyle and environmental factors and the incidence of cancer at various sites [1, 2]. The EPIC cohort was initiated in 1992 and has gradually grown into a multi-centre study recruiting 521,000 participants aged 35–70 years, among 23 centres in 10 European countries: Denmark, France, 作者: –LOUS 時間: 2025-3-29 00:19 作者: Aprope 時間: 2025-3-29 05:18 作者: Saline 時間: 2025-3-29 11:18
Cancer Prevention by Vaccination Against Hepatitis Bn papilloma virus and cervical cancer, and . and gastric cancer. The first evidence of cancer prevention by vaccination in humans was provided by HBV vaccination in infants. Chronic HBV is related to approximately 60%–90% of hepatocellular carcinomas (HCC) in adults and nearly 100% of childhood HCC 作者: 北極熊 時間: 2025-3-29 12:46
Energy Restriction for Breast Cancer Preventionsociated with a reduction in risk of postmenopausal breast cancer. Here we summarise lifestyle changes including continuous or intermittent energy restriction and/or exercise which may be beneficial for preventing breast cancer and also potential pharmacological approaches to prevention using energy作者: 防御 時間: 2025-3-29 19:12
The Use of Tamoxifen and Raloxifene for the Prevention of Breast Canceren at increased risk for breast cancer to determine the relative effects on the risk of invasive breast cancer. To be eligible for participation, a woman had to be healthy with at least a 5-year predicted breast cancer risk of 1.66% based on the Gail model or a history of lobular carcinoma in situ (作者: 美學(xué) 時間: 2025-3-29 20:21 作者: Finasteride 時間: 2025-3-30 01:29 作者: 改進(jìn) 時間: 2025-3-30 05:17 作者: FICE 時間: 2025-3-30 09:16 作者: 共和國 時間: 2025-3-30 15:27
Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Preventionce suggests that selenium and vitamin E may decrease the risk of this disease. The Selenium and Vitamin E Cancer Prevention Trial (SELECT), a phase III randomized, placebo-controlled study, is designed to determine whether selenium and vitamin E, alone or in combination, decrease the risk of prostat作者: 大酒杯 時間: 2025-3-30 18:06
Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studieit may account for the more than 50 years natural history from first infection to cancer. Though as yet there is no clear-cut specific associated infection, there is clear evidence that some sexually acquired infections damage the prostate and increase serum PSA with slow recovery back to normal. Th作者: 美色花錢 時間: 2025-3-31 00:33 作者: verdict 時間: 2025-3-31 01:09 作者: SPURN 時間: 2025-3-31 08:57 作者: 領(lǐng)先 時間: 2025-3-31 10:06 作者: adroit 時間: 2025-3-31 15:05
https://doi.org/10.1007/978-3-540-69297-3ER-negative breast cancer; Prevention of breast cancer; Primary prevention; cancer prevention; chemoprev作者: ABOUT 時間: 2025-3-31 19:58
978-3-642-08881-0Springer-Verlag Berlin Heidelberg 2009作者: MAG 時間: 2025-4-1 01:40
Chris R. de Freitas,Martin PerryAbstract Research concerning “cancer energetics” has become a popular area of investigation. This topic comprises two distinct fields: energetics at (1) the cellular level and (2) the whole organism level. Both of these have relevance to Cancer Risk and Cancer Prevention.作者: ALIBI 時間: 2025-4-1 02:30
Energy Metabolism, Cancer Risk, and Cancer PreventionAbstract Research concerning “cancer energetics” has become a popular area of investigation. This topic comprises two distinct fields: energetics at (1) the cellular level and (2) the whole organism level. Both of these have relevance to Cancer Risk and Cancer Prevention.作者: 燕麥 時間: 2025-4-1 06:32
Promises and Limitations of Biomarkersd for predicting response to therapy. Ye t very few markers are brought to clinical practice, and many are not even found to be reproducible. This essay discusses chance and bias as threats to validity that can explain the huge disconnect between promise and product, along with approaches to address those threats.作者: CHURL 時間: 2025-4-1 12:10 作者: Conflagration 時間: 2025-4-1 17:16
